e-learning
resources
Copenhagen 2005
Sunday 18.09.2005
From molecules to patients: mechanisms of lung injury, fibrosis and cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Tyrosine kinase inhibition of human pulmonary fibroblast migration
K. Vuorinen, V. Kinnula, M. Myllärniemi (Helsinki, Finland)
Source:
Annual Congress 2005 - From molecules to patients: mechanisms of lung injury, fibrosis and cancer
Session:
From molecules to patients: mechanisms of lung injury, fibrosis and cancer
Session type:
Thematic Poster Session
Number:
725
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
K. Vuorinen, V. Kinnula, M. Myllärniemi (Helsinki, Finland). Tyrosine kinase inhibition of human pulmonary fibroblast migration. Eur Respir J 2005; 26: Suppl. 49, 725
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Bone morphogenetic proteins (BMPs) inhibit hypoxia stimulated human pulmonary artery fibroblast (PAF) proliferation via inhibition of p38 MAP kinase and HIF-1α
Source: Annual Congress 2004 - Pathophysiology of pulmonary hypertension
Year: 2004
Molecular mechanisms of the synergy between cysteinyl-leukotrienes and receptor tyrosine kinase growth factors on human bronchial fibroblast proliferation
Source: Eur Respir Rev 2006; 15: 172-174
Year: 2006
Molecular mechanisms of the synergy between cysteinyl-leukotrienes and receptor tyrosine kinase growth factors on human bronchial fibroblast proliferation
Source: Eur Respir J 2006; 28: Suppl. 50, 339s
Year: 2006
Bradykinin phosphorylates ERK1/2 through epidermal growth factor receptor transactivation in human lung fibroblasts
Source: Eur Respir J 2005; 26: Suppl. 49, 341s
Year: 2005
Transforming growth factor-β inhibition of lung fibroblast proliferation is mediated through prostaglandin E
2
,
via
activation of p38 mitogen-activated protein kinase
Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Year: 2005
Use of multitarget tyrosine kinase inhibitors to attenuate platelet-derived growth factor signalling in lung disease
Source: Eur Respir Rev, 26 (146) 170061; 10.1183/16000617.0061-2017
Year: 2017
Protein tyrosine phosphatase-alpha (PTPa) promotes profibrotic responses in lung fibroblasts
Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis
Year: 2017
Effect of PDGF receptor tyrosine kinase inhibitor AG1296 on bleomycin-induced lung fibrosis in mice
Source: Annual Congress 2004 - Pulmonary fibrosis - new insights
Year: 2004
IL18 induces p38 MAP kinase activation and adhesion capacities in BMPRII knocked down human lung microvascular endothelial cells
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
Transmission of muscarinic receptor mediated proliferative effects in human lung fibroblasts involves ERK-MAP kinase, but not PI-3 kinase and Rho-kinase pathway
Source: Annual Congress 2007 - Miscellaneous pulmonary pharmacology
Year: 2007
Effects of glucocorticoids on activation of extracellular signal-regulated kinases (ERK) in human pulmonary endothelial cells
Source: Eur Respir J 2001; 18: Suppl. 33, 160s
Year: 2001
Transforming growth factor-α (TGF-α)-induced interleukin-8 (IL-8) release in human bronchial epithelial cells in vitro: role of mitogen-activated protein kinases (MAPK)
Source: Eur Respir J 2002; 20: Suppl. 38, 573s
Year: 2002
Role of phosphatidylinositol-3-kinase (PI3K) in TGF-β-induced proliferation and differentiation of human lung fibroblasts into myofibroblasts
Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis
Year: 2011
FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl
Source: Eur Respir J 2011; 37: 78-88
Year: 2011
Differential role of EPAC and PKA in the transduction of cAMP-mediated inhibition of human lung fibroblast proliferation and collagen synthesis
Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation
Year: 2009
PDGF and Src tyrosine kinases in pulmonary arterial smooth muscle cells: Effects of dasatinib and nilotinib on pulmonary vascular remodeling
Source: Annual Congress 2011 - Treatments for pulmonary hypertension in human and experimental models
Year: 2011
Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway
Source: Eur Respir J 2008; 31: 523-531
Year: 2008
Jun kinase regulates the expression of TGF-beta induced connective tissue growth factor in human lung fibroblast
Source: Annual Congress 2004 - Inflammation and remodelling in human lungs
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept